209 min. Cell concentrations were adjusted to 1x10 6 cells/mL in RPMI medium (Sigma, 210 USA) supplemented with 10% fetal bovine serum (Cultilab, Campinas, Brazil) . After 211 washing, spleen cell suspensions were incubated with 25μM
212 carboxyfluoresceinsuccinimidyl probe ester (CFSE) in RPMI-10% FBS at room 213 temperature for 5 min, according manufacturer's recommendations (Invitrogen, USA).
214 Cells were then pelleted by centrifugation and suspended in fresh medium. To 215 determine the maximum uptake of CFSE, aliquots of each cell suspension were fixed 216 with 1% formaldehyde in PBS and analyzed by flow cytometer. Then 100μL aliquots of 217 each suspension of CFSE-labeled cells were seeded in duplicate in 96-well plates 218 (Corning) and incubated in the presence of 2.5 μg / ml ConA for 72 hours at 37° C.
219 Cultures of cells conducted in the absence of Con-A were used as controls. 266 Weight loss in TNBS-induced colitis is generally mild (about 10%) and recovery of 267 body weight is usually observed as early as the fourth day after drug administration in 268 BALB/c mice. As can be seen in Figure 2A , the adoptive transfers of BMDC CTLA4-Ig or 269 BMDC naïve did not result in any significant improvement in weight loss observed in the 270 first days after TNBS instillation and, as expected, by the fourth day all mice had 271 already recovered. However, the other clinical signs of the disease (diarrhea, rectal 272 prolapse, soft stools, and hemorrhagic stools) were significantly reduced by previous 273 treatment with BMDC CTLA4-Ig , as shown in Figure 2B . 280 The cells present in the infiltrate consisted mainly of macrophages ( Figure 3B ), while 281 neutrophils were rarely found. It was also observed that the colonic tissue of mice 282 treated with BMDC CTLA4-Ig showed a significant reduction in the number of infiltrated 283 macrophages when compared to the tissues of mice without previous treatment with 284 BMDCs. Pretreatment with BMDC naïve did not modify the inflammatory process 285 induced by the instillation of TNBS. On the other hand, the adoptive transfer of 286 BMDC CTLA4-Ig , but not BMDC naïve , was able to prevent thickening of the colon wall, 287 particularly in the P1 region, as shown in Figure 3C . 422 Although the frequencies of IL-17 and IFN-γ-secreting T cells were reduced in splenic 423 cell cultures of mice pretreated with BMDC CTLA4-Ig , no significant differences were 424 observed in the levels of these cytokines in spleen cell culture supernatants from mice 425 pretreated with either BMDC CTLA4-Ig or BMDC naïve . On the other hand, IL-4, whose 426 production is controlled by GATA-3 expression, was detected only in spleen cell 427 cultures of BMDC CTLA4-Ig treated mice. In the spleen cell cultures from mice pretreated 428 with BMDC naïve it was possible to observe the higher levels of IL-6, but it was also the 429 one that presented the highest levels of IL-10, whose production is controlled by the 430 transcription factor Foxp3. 
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